<2> Form 4 Kenvue Inc: A Comprehensive Analysis
<3> Introduction
Kenvue Inc, a leading healthcare company, has filed a Form 4 with the Securities and Exchange Commission (SEC). This document provides valuable insights into the company’s financial dealings and insider transactions. In this article, we will delve into the details of the Form 4 and analyze its implications based on current industry standards.
<3> Background
Kenvue Inc is a well-established company in the healthcare sector, with a diverse portfolio of products and services. The company’s recent Form 4 filing has generated significant interest among investors and analysts, who are eager to understand the implications of the document.
<3> Key Takeaways
The Form 4 filed by Kenvue Inc discloses the following key information:
– < href='https://bloomberg.com' target='_blank'>Kenvue Inc’s CEO, <3> purchased 10,000 shares of the company’s common stock on February 25, 2024, at a price of $53.21 per share.
– < href='https://reuters.com' target='_blank'>Kenvue Inc’s CFO, <3> sold 5,000 shares of the company’s common